300 related articles for article (PubMed ID: 32282596)
1. Final Program Data and Factors Associated With Long-Acting Reversible Contraception Removal: The Zika Contraception Access Network.
Lathrop E; Hurst S; Mendoza Z; Zapata LB; Cordero P; Powell R; Green C; Moreno N; Jamieson DJ; Romero L
Obstet Gynecol; 2020 May; 135(5):1095-1103. PubMed ID: 32282596
[TBL] [Abstract][Full Text] [Related]
2. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
[TBL] [Abstract][Full Text] [Related]
3. Strategies and safeguards to ensure access to long-acting reversible contraception removal after the Zika Contraception Access Network ended: A prospective analysis of patient reported complaints.
Romero L; Mendoza Z; Hurst S; Zapata LB; Powell R; Vale Y; Lathrop E
Contraception; 2020 Nov; 102(5):356-360. PubMed ID: 32858052
[TBL] [Abstract][Full Text] [Related]
4. The Role of Public-Private Partnerships to Increase Access to Contraception in an Emergency Response Setting: The Zika Contraception Access Network Program.
Romero L; Mendoza ZV; Croft L; Bhakta R; Sidibe T; Bracero N; Malave C; Suarez A; Sanchez L; Cordero D; Lathrop E; Monroe J
J Womens Health (Larchmt); 2020 Nov; 29(11):1372-1380. PubMed ID: 33196331
[TBL] [Abstract][Full Text] [Related]
5. Program Fidelity and Patient Satisfaction among Women Served by the Zika Contraception Access Network Program in Puerto Rico.
Zapata LB; Romero L; Rivera MI; Rivera-Soto SK; Hurst S; Mendoza ZV; Clayton HB; Bracero N; Whiteman MK; Lathrop E
Womens Health Issues; 2020; 30(4):268-276. PubMed ID: 32376188
[TBL] [Abstract][Full Text] [Related]
6. Long-acting reversible contraception use and unmet desire among patients after the Zika Contraception Access Network Program in Puerto Rico.
Stewart A; Romero L; Kortsmit K; Hurst S; Powell R; Lathrop E; Whiteman MK; Zapata LB
Contraception; 2024 Jul; 135():110441. PubMed ID: 38552819
[TBL] [Abstract][Full Text] [Related]
7. Access to Contraceptive Services in Puerto Rico: An Analysis of Policy and Practice Change Strategies, 2015-2018.
Romero L; Corrada-Rivera RM; Huertas-Pagan X; Aquino-Serrano FV; Morales-Boscio AM; Sanchez-Cesareo M; Acosta-Perez E; Mendoza Z; Lathrop E
J Public Health Manag Pract; 2022 Mar-Apr 01; 28(2):E506-E517. PubMed ID: 33729201
[TBL] [Abstract][Full Text] [Related]
8. Contraception as a Medical Countermeasure to Reduce Adverse Outcomes Associated With Zika Virus Infection in Puerto Rico: The Zika Contraception Access Network Program.
Romero L; Koonin LM; Zapata LB; Hurst S; Mendoza Z; Lathrop E;
Am J Public Health; 2018 Sep; 108(S3):S227-S230. PubMed ID: 30192658
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of the Zika Virus, Contraceptive Access, and Motivation to Participate in the Zika Contraception Access Network Program: Qualitative Analysis of Focusgroup Discussions with Puerto Rican Women.
Romero L; Acosta-Pérez E; Bednar H; Hurst S; Zapata LB; Vega-Torres S; Powell R; Lathrop E
P R Health Sci J; 2024 Mar; 43(1):46-53. PubMed ID: 38512761
[TBL] [Abstract][Full Text] [Related]
10. Estimating Contraceptive Needs and Increasing Access to Contraception in Response to the Zika Virus Disease Outbreak--Puerto Rico, 2016.
Tepper NK; Goldberg HI; Bernal MI; Rivera B; Frey MT; Malave C; Renquist CM; Bracero NJ; Dominguez KL; Sanchez RE; Shapiro-Mendoza CK; Rodriguez BR; Simeone RM; Pesik NT; Barfield WD; Ko JY; Galang RR; Perez-Padilla J; Polen KN; Honein MA; Rasmussen SA; Jamieson DJ
MMWR Morb Mortal Wkly Rep; 2016 Apr; 65(12):311-4. PubMed ID: 27031817
[TBL] [Abstract][Full Text] [Related]
11. Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.
Boulet SL; D'Angelo DV; Morrow B; Zapata L; Berry-Bibee E; Rivera M; Ellington S; Romero L; Lathrop E; Frey M; Williams T; Goldberg H; Warner L; Harrison L; Cox S; Pazol K; Barfield W; Jamieson DJ; Honein MA; Kroelinger CD
MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):780-7. PubMed ID: 27490117
[TBL] [Abstract][Full Text] [Related]
12. Community Understanding of Contraception During the Zika Virus Outbreak in Puerto Rico.
August EM; Rosenthal J; Torrez R; Romero L; Berry-Bibee EN; Frey MT; Torres R; Rivera-García B; Honein MA; Jamieson DJ; Lathrop E
Health Promot Pract; 2020 Jan; 21(1):133-141. PubMed ID: 31142152
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of Increasing Access to Contraception during the Zika Virus Outbreak, Puerto Rico, 2016.
Li R; Simmons KB; Bertolli J; Rivera-Garcia B; Cox S; Romero L; Koonin LM; Valencia-Prado M; Bracero N; Jamieson DJ; Barfield W; Moore CA; Mai CT; Korhonen LC; Frey MT; Perez-Padilla J; Torres-Muñoz R; Grosse SD
Emerg Infect Dis; 2017 Jan; 23(1):74-82. PubMed ID: 27805547
[TBL] [Abstract][Full Text] [Related]
14. Continuation of Reversible Contraception Following Enrollment in the Zika Contraception Access Network (Z-CAN) in Puerto Rico, 2016-2020.
Zapata LB; Kortsmit K; Curtis KM; Romero L; Hurst S; Lathrop E; Acosta Perez E; Sánchez Cesáreo M; Whiteman MK
Stud Fam Plann; 2024 Jun; 55(2):105-125. PubMed ID: 38659169
[TBL] [Abstract][Full Text] [Related]
15. Economic evaluation of Zika Contraception Access Network in Puerto Rico during the 2016-17 Zika virus outbreak.
Li R; Ellington SR; Galang RR; Grosse SD; Mendoza Z; Hurst S; Vale Y; Lathrop E; Romero L
Contraception; 2022 Mar; 107():68-73. PubMed ID: 34748752
[TBL] [Abstract][Full Text] [Related]
16. Assessment of contraceptive use in Puerto Rico during the 2016 Zika virus outbreak.
Ellington SR; Rodriguez RS; Goldberg H; Bertolli J; Simeone RM; Mercado AS; Pazol K; Jamieson DJ; Honein MA; Swartzendruber A; Miles T; Cordero JF; Shapiro-Mendoza CK
Contraception; 2020 Jun; 101(6):405-411. PubMed ID: 32194040
[TBL] [Abstract][Full Text] [Related]
17. Provider Perceptions of Facilitators of and Barriers to Implementation of the Zika Contraception Access Network: A Qualitative Evaluation.
Acosta-Pérez E; Lathrop E; Vega S; Zapata LB; Mendoza Z; Huertas-Pagán X; Hurst S; Powell R; Romero L
P R Health Sci J; 2023 Sep; 42(3):233-240. PubMed ID: 37709681
[TBL] [Abstract][Full Text] [Related]
18. Physician and clinic staff attitudes and practices during implementation of the Zika Contraception Access Network.
Tepper NK; Zapata LB; Hurst S; Curtis KM; Lathrop E; Romero L; Acosta-Perez E; Mendoza Z; Whiteman MK
Contraception; 2020 Jul; 102(1):34-38. PubMed ID: 32298716
[TBL] [Abstract][Full Text] [Related]
19. Contraceptive sales in the setting of the Zika virus epidemic.
Bahamondes L; Ali M; Monteiro I; Fernandes A
Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
[TBL] [Abstract][Full Text] [Related]
20. Condom use among women of reproductive age (18-49 years) in Puerto Rico during the 2016 Zika virus outbreak: secondary analysis of data from a cross-sectional, population-based, cell-phone survey.
Chang KT; Snead MC; Serrano Rodriguez RA; Bish C; Shapiro-Mendoza CK; Ellington SR
BMJ Open; 2022 Jul; 12(7):e065592. PubMed ID: 35835533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
